Literature DB >> 10775647

Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells.

A Schultze-Mosgau1, A C Katzur, K K Arora, S S Stojilkovic, K Diedrich, O Ortmann.   

Abstract

In human ovarian EFO-21 and EFO-27 carcinoma cells, extracellular ATP induced a concentration-dependent rise in intracellular calcium concentration ([Ca(2+)](i)), suggesting the expression of a purinoreceptor. ATP and UTP were equipotent in generating [Ca(2+)](i) signals, followed by ATP-gamma-S and ADP, whereas beta, gamma-ATP, 2 methyl 1 thio-ATP, 3'-o-(4-benzoyl) benzoyl-ATP, AMP, and adenosine were ineffective. This pharmacological profile suggested the presence of the P2Y(2) subtype in both cell types, and this was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) analysis using P2Y(2) primers. ATP-induced [Ca(2+)](i) signals were composed of two phases: an early and extracellular calcium-independent phase, followed by a sustained plateau phase that was dependent on capacitative calcium influx. In addition to the rise in the [Ca(2+)](i), a time- and concentration-dependent increase in phosphatidylethanol accumulation was observed in ATP-stimulated cells, indicating an increase in phospholipase D activity. RT-PCR analysis identified the expression of a transcript for the phospholipase D-1 subtype of this enzyme. Activation of these receptors by a slowly degradable analogue, ATP-gamma-S, attenuated basal and fetal calf serum-induced cell proliferation in a time- and concentration-dependent manner. These results indicate that ATP may act as an extracellular messenger in controlling the ovarian epithelial cell cycle through P2Y(2) receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775647     DOI: 10.1093/molehr/6.5.435

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  13 in total

1.  A new perspective of mechanosensitive pannexin-1 channels in cancer metastasis: clues for the treatment of other stress-induced diseases.

Authors:  Di Wu; Lanfang Li; Linxi Chen
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-29       Impact factor: 3.848

Review 2.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

Review 3.  Neurotransmitter receptors as signaling platforms in anterior pituitary cells.

Authors:  Hana Zemková; Stanko S Stojilkovic
Journal:  Mol Cell Endocrinol       Date:  2017-07-03       Impact factor: 4.102

4.  Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y2 receptor antagonist.

Authors:  Nicole Brockmann; Parichat Sureechatchaiyan; David Müller; Tatiana Hennicke; Ralf Hausmann; Gerhard Fritz; Alexandra Hamacher; Matthias U Kassack
Journal:  Purinergic Signal       Date:  2019-07-03       Impact factor: 3.765

Review 5.  Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors.

Authors:  Tamás Deli; László Csernoch
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

6.  ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2/Bax ratio in lung cancer cells.

Authors:  Shanshan Song; Krista N Jacobson; Kimberly M McDermott; Sekhar P Reddy; Anne E Cress; Haiyang Tang; Steven M Dudek; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-21       Impact factor: 4.249

Review 7.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

Review 8.  P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.

Authors:  Lucas T Woods; Kevin Muñoz Forti; Vinit C Shanbhag; Jean M Camden; Gary A Weisman
Journal:  Biochem Pharmacol       Date:  2021-01-04       Impact factor: 5.858

9.  Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors.

Authors:  K Maaser; M Höpfner; H Kap; A P Sutter; B Barthel; B von Lampe; M Zeitz; H Scherübl
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

Review 10.  Mitogen-activated protein kinases in normal and (pre)neoplastic ovarian surface epithelium.

Authors:  Kyung-Chul Choi; Nelly Auersperg; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.